TRANSFORMATION OF ESTRONE AND ESTRADIOL IN HORMONE-DEPENDENT AND HORMONE-INDEPENDENT HUMAN BREAST-CANCER CELLS - EFFECTS OF THE ANTIESTROGEN ICI-164,384, DANAZOL, AND PROMEGESTONE (R-5020)
Bl. Nguyen et al., TRANSFORMATION OF ESTRONE AND ESTRADIOL IN HORMONE-DEPENDENT AND HORMONE-INDEPENDENT HUMAN BREAST-CANCER CELLS - EFFECTS OF THE ANTIESTROGEN ICI-164,384, DANAZOL, AND PROMEGESTONE (R-5020), Breast cancer research and treatment, 34(2), 1995, pp. 139-146
Using different hormone-dependent (MCF-7, T-47D) and hormone-independe
nt (MDA-MB-231, Hs-578S, MDA-MB-436) human breast cancer cells, the in
terconversion estrone (E(1)) reversible arrow estradiol (E(2)) was exp
lored. The data show very clearly that in the hormone-dependent cells
the tendency is to form E(2) after incubation with E(1), whereas after
incubation with E(2) most of this estrogen cells, in contrast most of
E(1) remains E(1), while E(2) is converted into E(1). The tendency of
the reductive reversible arrow oxidative direction is supported by th
e analysis of estrogens in the culture medium. To explore the possible
action of different drugs on the 17 beta-hydroxysteroid dehydrogenase
(17 beta-HSD) activity, it was observed that the potent antiestrogen
ICI 164,384 inhibits the conversion of E(1) to E(2), while a lesser ef
fect is observed with Danazol and only weak inhibition is obtained wit
h the progestagen Promegestone (R-5020). It is concluded that the orie
ntation of 17 beta-HSD activity for the interconversion E(1) reversibl
e arrow E(2) in hormone-dependent and -independent cells is related to
the hormonal status of the cells.